← back to search

Isabelle Opitz

University Hospital of Zurich · CH
Area of research
Pulmonary and Respiratory Medicine · Biotechnology
Research interest
Research interests include Occupational and environmental lung diseases, Pleural and Pulmonary Diseases, Lung Cancer Diagnosis and Treatment, and Medical Imaging and Pathology Studies.
h-index
48
citations
11,662
works
553
NIH funding
primary concept
Medicine
email

Recent publications

The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer
The Annals of Thoracic Surgery 2025cited by 17position: middledoi
Pleural mesothelioma
Nature Reviews Disease Primers 2025cited by 13position: middledoi
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the “T” Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma
Journal of Thoracic Oncology 2024cited by 35position: middledoi
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma
Journal of Thoracic Oncology 2024cited by 23position: middledoi
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the “N” Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma
Journal of Thoracic Oncology 2024cited by 15position: middledoi
IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer
Journal of Thoracic Oncology 2023cited by 123position: middledoi
European Society of Thoracic Surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer
European Journal of Cardio-Thoracic Surgery 2023cited by 64position: middledoi
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
European Heart Journal 2022cited by 3,528position: middledoi
ERS/ESTS statement on the management of pleural infection in adults
European Respiratory Journal 2022cited by 127position: middledoi
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
Journal of Thoracic Oncology 2022cited by 92position: middledoi
The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: The use of mechanical circulatory support in lung transplantation
Journal of Thoracic and Cardiovascular Surgery 2022cited by 71position: middledoi
CD26-inhibition correlates with the absence of chronic lung allograft dysfunction and decreases fibroblast activity in vitro
British journal of surgery 2022cited by 1position: middledoi
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
European Respiratory Journal 2020cited by 262position: middledoi
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
European Journal of Cardio-Thoracic Surgery 2020cited by 112position: firstdoi
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach
Journal of Thoracic Oncology 2019cited by 154position: middledoi
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer
Journal of Thoracic Oncology 2019cited by 152position: middledoi
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
Journal of Thoracic Oncology 2017cited by 84position: middledoi
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
Journal of Thoracic Oncology 2016cited by 177position: middledoi
Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group
Lung Cancer 2016cited by 47position: middledoi
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
The Lancet Oncology 2015cited by 200position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

R. Taylor Ripley · Baylor College of Medicine4 papers (2024–2025)Anna K. Nowak · St George's, University of London4 papers (2016–2024)Hedy L. Kindler · Public Health Ontario3 papers (2024–2024)Andrea Wolf · Goethe University Frankfurt3 papers (2024–2024)Harvey I. Pass · NYU Langone Health3 papers (2024–2024) · 3 papers (2024–2024)Ritu R. Gill · Columbia University Irving Medical Center3 papers (2024–2024)Valerie W. Rusch · Cornell University3 papers (2024–2024) · 2 papers (2024–2024)Andrea Billè · Guy's Hospital2 papers (2024–2024)David C. Rice · The University of Texas MD Anderson Cancer Center2 papers (2024–2024)Varun Puri · McMaster University1 papers (2022–2022) · 1 papers (2015–2015)Marcelo Cypel · Hospital for Sick Children1 papers (2022–2022)Maged Hassan · Helwan University1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2015–2015)Pallavi Sood · University of Florida1 papers (2025–2025) · 1 papers (2015–2015) · 1 papers (2022–2022)